Cargando…

HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP

BACKGROUND: Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated myelopathy/tropical spastic paraparesis. In contrast to another human retrovirus, human immunodeficiency virus type 1 (HIV-1), HTLV-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazato, Paola, Matsuo, Misaki, Tan, Benjy J. Y., Tokunaga, Michiyo, Katsuya, Hiroo, Islam, Saiful, Ito, Jumpei, Murakawa, Yasuhiro, Satou, Yorifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915898/
https://www.ncbi.nlm.nih.gov/pubmed/31842935
http://dx.doi.org/10.1186/s12977-019-0500-3
_version_ 1783480117615394816
author Miyazato, Paola
Matsuo, Misaki
Tan, Benjy J. Y.
Tokunaga, Michiyo
Katsuya, Hiroo
Islam, Saiful
Ito, Jumpei
Murakawa, Yasuhiro
Satou, Yorifumi
author_facet Miyazato, Paola
Matsuo, Misaki
Tan, Benjy J. Y.
Tokunaga, Michiyo
Katsuya, Hiroo
Islam, Saiful
Ito, Jumpei
Murakawa, Yasuhiro
Satou, Yorifumi
author_sort Miyazato, Paola
collection PubMed
description BACKGROUND: Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated myelopathy/tropical spastic paraparesis. In contrast to another human retrovirus, human immunodeficiency virus type 1 (HIV-1), HTLV-1 persists in the host not via vigorous virus production but mainly via proliferation and/or long-term survival in the form of silent proviruses in infected host cells. As a result, HTLV-1-infected cells rarely produce virus particles in vivo even without anti-retroviral treatment. That should be an advantage for the virus to escape from the host immune surveillance by minimizing the expression of viral antigens in host cells. However, why HIV-1 and HTLV-1 behave so differently during natural infection is not fully understood. RESULTS: We performed cap analysis of gene expression (CAGE) using total RNAs and nascent, chromatin-associated, RNAs in the nucleus and found that HTLV-1 RNAs were processed post-transcriptionally in infected cells. RNA processing was evident for the sense viral transcripts but not the anti-sense ones. We also found a higher proportion of CG di-nucleotides in proviral sequences of HTLV-1-infected cells, when compared to the HIV-1 genomic sequence. It has been reported recently that CG dinucleotide content of viral sequence is associated with susceptibility to the antiviral ZC3HAV1 (ZAP), suggesting the involvement of this protein in the regulation of HTLV-1 transcripts. To analyse the effect of ZAP on HTLV-1 transcripts, we over-expressed it in HTLV-1-infected cells. We found there was a dose-dependent reduction in virus production with ZAP expression. We further knocked down endogenous ZAP with two independent targeting siRNAs and observed a significant increase in virus production in the culture supernatant. Other delta-type retroviruses such as simian T-cell leukaemia virus and bovine leukaemia virus, also contain high CG-dinucleotide contents in their viral genomes, suggesting that ZAP-mediated suppression of viral transcripts might be a common feature of delta-type retroviruses, which cause minimal viremia in their natural hosts. CONCLUSIONS: The post-transcriptional regulatory mechanism involving ZAP might allow HTLV-1 to maintain a delicate balance required for prolonged survival in infected individuals.
format Online
Article
Text
id pubmed-6915898
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69158982019-12-30 HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP Miyazato, Paola Matsuo, Misaki Tan, Benjy J. Y. Tokunaga, Michiyo Katsuya, Hiroo Islam, Saiful Ito, Jumpei Murakawa, Yasuhiro Satou, Yorifumi Retrovirology Research BACKGROUND: Human T cell leukaemia virus type 1 (HTLV-1) is a retrovirus associated with human diseases such as adult T-cell leukaemia/lymphoma and HTLV-1 associated myelopathy/tropical spastic paraparesis. In contrast to another human retrovirus, human immunodeficiency virus type 1 (HIV-1), HTLV-1 persists in the host not via vigorous virus production but mainly via proliferation and/or long-term survival in the form of silent proviruses in infected host cells. As a result, HTLV-1-infected cells rarely produce virus particles in vivo even without anti-retroviral treatment. That should be an advantage for the virus to escape from the host immune surveillance by minimizing the expression of viral antigens in host cells. However, why HIV-1 and HTLV-1 behave so differently during natural infection is not fully understood. RESULTS: We performed cap analysis of gene expression (CAGE) using total RNAs and nascent, chromatin-associated, RNAs in the nucleus and found that HTLV-1 RNAs were processed post-transcriptionally in infected cells. RNA processing was evident for the sense viral transcripts but not the anti-sense ones. We also found a higher proportion of CG di-nucleotides in proviral sequences of HTLV-1-infected cells, when compared to the HIV-1 genomic sequence. It has been reported recently that CG dinucleotide content of viral sequence is associated with susceptibility to the antiviral ZC3HAV1 (ZAP), suggesting the involvement of this protein in the regulation of HTLV-1 transcripts. To analyse the effect of ZAP on HTLV-1 transcripts, we over-expressed it in HTLV-1-infected cells. We found there was a dose-dependent reduction in virus production with ZAP expression. We further knocked down endogenous ZAP with two independent targeting siRNAs and observed a significant increase in virus production in the culture supernatant. Other delta-type retroviruses such as simian T-cell leukaemia virus and bovine leukaemia virus, also contain high CG-dinucleotide contents in their viral genomes, suggesting that ZAP-mediated suppression of viral transcripts might be a common feature of delta-type retroviruses, which cause minimal viremia in their natural hosts. CONCLUSIONS: The post-transcriptional regulatory mechanism involving ZAP might allow HTLV-1 to maintain a delicate balance required for prolonged survival in infected individuals. BioMed Central 2019-12-16 /pmc/articles/PMC6915898/ /pubmed/31842935 http://dx.doi.org/10.1186/s12977-019-0500-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Miyazato, Paola
Matsuo, Misaki
Tan, Benjy J. Y.
Tokunaga, Michiyo
Katsuya, Hiroo
Islam, Saiful
Ito, Jumpei
Murakawa, Yasuhiro
Satou, Yorifumi
HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title_full HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title_fullStr HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title_full_unstemmed HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title_short HTLV-1 contains a high CG dinucleotide content and is susceptible to the host antiviral protein ZAP
title_sort htlv-1 contains a high cg dinucleotide content and is susceptible to the host antiviral protein zap
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915898/
https://www.ncbi.nlm.nih.gov/pubmed/31842935
http://dx.doi.org/10.1186/s12977-019-0500-3
work_keys_str_mv AT miyazatopaola htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT matsuomisaki htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT tanbenjyjy htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT tokunagamichiyo htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT katsuyahiroo htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT islamsaiful htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT itojumpei htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT murakawayasuhiro htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap
AT satouyorifumi htlv1containsahighcgdinucleotidecontentandissusceptibletothehostantiviralproteinzap